Pharma braces for new regulations that test ERP's quality, manufacturing tools

In November 2013, legislators initially introduced the Drug Quality and Security Act (DQSA) - a proposed law that would include the Compounding Quality Act and the Drug Supply Chain Security Act. The first sets up a voluntary compliance arrangement for pharmaceutical firms and the other requires the FDA to develop a national track-and-trace system that manufacturers must use when introducing products into the supply chain. 

The bill was signed into law in 2013, but manufacturers had until January 2015 to implement portions of the required labeling, tracking, and paperwork. A company's ability to meet those standards will depend in large part on the capabilities of their existing ERP system.


Requires FREE Membership to View

Become a Member Joining gives you free, unlimited access to news, analysis, white papers, case studies, product brochures, and more, and it’s all FREE. You’ll also receive periodic email newsletters with the latest relevant articles and content updates.
About Bridget McCrea

Bridget McCrea covers business and technology topics for various publications. She can be reached at

Read full bio...